UPDATED 20.02.2014 13:04

Organised cervical cancer screening programme in the Helsinki region in Finland in the invitation year 2006. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 56930 643 1.13 4 0.01 2 0.00 9 0.02 38 0.07 107 0.19 70 0.12 413 0.73
I 52968 1 - - - - - - - - - - - - - 1 -
II 3245 47 0.08 - - - - - - - - - - 3 0.01 44 0.08
III 557 552 0.97 2 - 2 - 4 0.01 21 0.04 98 0.17 64 0.11 361 0.63
IV 42 42 0.07 2 - - - 4 0.01 17 0.03 9 0.02 3 0.01 7 0.01
V 1 1 - - - - - 1 - - - - - - - - -
Inadequate 106 - - - - - - - - - - - - - - - -
Unknown 11 - - - - - - - - - - - - - - - -
HPV test 16771 302 1.80 4 0.02 1 0.01 10 0.06 26 0.16 53 0.32 43 0.26 165 0.98
Negative1 14971 6 0.04 - - - - - - - - - - 1 0.01 5 0.03
Positive2 1800 296 1.76 4 0.02 1 0.01 10 0.06 26 0.16 53 0.32 42 0.25 160 0.95
Total 73701 945 1.28 8 0.01 3 0.00 19 0.03 64 0.09 160 0.22 113 0.15 578 0.78

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.